Amma A. Benneh-Akwasi Kuma

Amma A. Benneh-Akwasi Kuma

Auto-generated profile, based on publicly available information

Amma A. Benneh-Akwasi Kuma

Department of Haematology, College of Health Sciences, University of Ghana, Accra, Ghana

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2018 in Advances in Hematology
Verified
Journal Article
Open access
PDF file
EAEugenia V. Asare
Eugenia V. Asare
IWIvor Wilson
Ivor Wilson
AKAmma A. Benneh-Akwasi Kuma
Amma A. Benneh-Akwasi Kuma
YDYvonne Dei-Adomakoh
Yvonne Dei-Adomakoh
FSFredericka Sey
Fredericka Sey
EOEdeghonghon Olayemi
Edeghonghon Olayemi
In Africa, sickle cell disease (SCD) is a major public health problem with over 200,000 babies born per year. In Ghana, approximately 15,000 (2%) of Ghanaian newborns are diagnosed with SCD annually. A retrospective review of medical records of all SCD patients aged 13 years and above, who presented to the sickle cell clinic at Ghana Institute of Clinical Genetics (GICG), Korle-Bu, from 1st January 2013 to 31st December 2014, was carried out, using a data abstraction instrument to document their phenotypes, demographics, attendance/clinic visits, pattern of attendance, and common complications seen. During the period under review 5,451 patients were seen at the GICG, with 20,788 clinic visits. The phenotypes were HbSS (55.7%) and HbSC (39.6%) with other sickle cell phenotypes (4.7%). Out of the 20,788 clinic visits, outpatient visits were 15,802 (76%), and urgent care visits were 4,986 (24%), out of which 128 (2.6%) patients were admitted to the Teaching Hospital for further management of their acute complications. There were 904 patient referrals (out of 5,451 patients) for specialist care; the 3 specialties that had the most referrals were Obstetrics and Gynaecology (168 patients), Orthopaedics (150 patients), and Ophthalmology (143 patients). In 2014, complications seen at KBTH included 53 patients with avascular necrosis (AVN) and 61 patients with chronic leg ulcers. Our centre has a large number of patients living with sickle cell disease. From our experience, early recognition and referral of sickle cell related complications can reduce morbidity and mortality associated with this disease. A multidisciplinary approach to care of SCD patients is therefore important.

1 January 2026 in Case Reports in Hematology
Verified
Journal Article
Open access
PDF file
AKAmma Benneh-Akwasi Kuma
Amma Benneh-Akwasi Kuma
LHLeticia Lokko Hanson
Leticia Lokko Hanson
NPNii Boi-Doku Pepra-Ameyaw
Nii Boi-Doku Pepra-Ameyaw
GOGeorge Dennis Obeng
George Dennis Obeng
MCMarcell Csanádi
Marcell Csanádi
Although life expectancy and survival have improved for CML patients due to the advent of tyrosine kinase inhibitor (TKI) therapies, the quality of life and family planning for women still hold challenges, especially in a resource‐limited setting where routine molecular monitoring and pregnancy‐compatible therapeutic options are limited. Due to their teratogenicity, TKI therapies are generally considered to be contraindicated during pregnancy. Here, we present case reports of three patients from the Korle‐Bu Teaching Hospital in Accra, Ghana, who were diagnosed with CML prior to pregnancy. A 29‐year‐old, 19‐year‐old and 33‐year‐old female were diagnosed with CML at the clinic. All patients initiated imatinib, which was stopped after confirming pregnancy. Patients were subsequently monitored with a monthly full blood count (FBC). While one of the patients was lost to follow‐up, the other two patients delivered without adverse events or fetal abnormalities and were able to restart imatinib therapy within 6 months. Based on the presented cases, a pragmatic framework emerges: (1) embed comprehensive counselling at diagnosis; (2) encourage planned conception only after sustained molecular remission; (3) stop TKIs upon pregnancy confirmation; (4) monitor with clear, communicated thresholds for intervention; (5) introduce cytoreduction after the first trimester only when clinically indicated and consent given; and (6) align postpartum feeding plans with timely TKI re‐initiation. As a conclusion, in contexts where social pressure to bear children is strong and pregnancy‐safe treatments are limited, transparent counselling, a remission‐first strategy, and tightly coordinated hematology–obstetric care offer the best path to balancing reproductive autonomy with maternal and fetal safety.

25 October 2026 in Hemoglobin
Verified
Journal Article
Closed access
EBErnest Boachie
Ernest Boachie
NPNii Boi-Doku Pepra-Ameyaw
Nii Boi-Doku Pepra-Ameyaw
NLNyanyuie Kodjo Lovi
Nyanyuie Kodjo Lovi
AKAmma Anima Benneh-Akwasi Kuma
Amma Anima Benneh-Akwasi Kuma
Hereditary persistence of fetal hemoglobin (HPFH) is a benign genetic condition characterized by continued expression of fetal hemoglobin (HbF) into adulthood. We report the case of a 26-year-old Ghanaian woman who was incidentally diagnosed with homozygous deletional HPFH during evaluation for flank pain. Laboratory testing revealed 100% HbF, erythrocytosis, and normal red cell indices. Family screening showed an identical phenotype in her monozygotic twin, an HbF level of 29% in her mother, and a normal hemoglobin electrophoresis pattern in one sibling. Homozygous deletional HPFH is rare, and this case contributes to the limited literature on adult presentations.